Effect of Clostridium perfringes beta antitoxin and colostral absorption on incidence of calf scours.
D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D000906:Antibodies; D000992:Antitoxins / Q000008:administration & dosage; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002417:Cattle; D002418:Cattle Diseases / Q000517:prevention & control*; D003015:Clostridium Infections / Q000662:veterinary*; D003016:Clostridium perfringens / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D003126:Colostrum / Q000276:immunology; D003967:Diarrhea / Q000517:prevention & control / Q000662:veterinary*; D004926:Escherichia coli / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D005260:Female; D006736:Horses; D007106:Immune Sera / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D012712:Serum Globulins
D000906:Antibodies; D000992:Antitoxins; D001428:Bacterial Vaccines; D007106:Immune Sera; D012712:Serum Globulins